Navigation Links
Bactolac Pharmaceutical Weighs In With New Year’s Resolution Support with Full-Service Weight Control Products Process

Hauppauge, NY (PRWEB) January 31, 2013

Weight loss is the top New Year’s resolution. Every year new weight control products are offered to the public, each hoping to gain market share and to succeed. Bactolac Pharmaceutical, a leading private label manufacturer of vitamins, herbal remedies, nutritional supplements and nutraceuticals has vast experience in this highly-competitive industry. The company offers the full-range production to market process that ensures new products designed to help consumers shed unwanted pounds will be both manufactured using the highest quality ingredients and distributed where consumers can readily access them.

“Bactolac Pharmaceutical has been assisting companies to manufacture, package and market private label supplements for over 17 years,” notes Renee Reynolds, Chief Financial Officer, Bactolac Pharmaceutical Inc. She continues, “Our Company employs highly skilled scientists to provide our clients with the formulas and services needed to bring their private label supplements competitively to market. Bactolac’s exceptional team also provides the most up-to-date research and development technologies and protocols in the industry to streamline the manufacturing process.”

Another way to ensure an optimal outcome when bringing a new weight control product to market is to align oneself with a company that is both certified and rigorously inspected. Bactolac Pharmaceutical, Inc. is certified by the Natural Products Association (NPA), Good Manufacturing Practices (GMP) Certification Program, NSF International (NSF), the Food and Drug Administration (FDA) and Quality Assurance International (QAI) - all the leading organizations and agencies whose mission is to uphold quality. In addition, Bactolac is certified by the Therapeutic Goods Administration (TGA), a status which only a select few nutritional supplement companies enjoy. Every raw material used is tested to ensure their quality meets or exceeds requirements for the nutraceutical industry as upheld by the US FDA. Bactolac’s science-based formulations and their high-tech micro and analytical laboratories ensure the efficacy and content of all their products.

As one of the leading nutritional supplement companies in the industry, Bactolac offers customers a wide variety of nutraceutical capsules, sublinguals, soft gels, chewables, tablets, and powders for private label manufacturing. Founded in New York in 1995, Bactolac’s goal has always been to provide high-quality vitamins and supplements at competitive prices to assist customers to become successful in the health and wellness supplementation market. As a full-service health supplement manufacturer and vitamin supplier, the firm offers product manufacturing, to product testing, packaging, labeling and distribution. These processes are all carried out in their state-of-the-art, 175,000 sq. ft. facility, which houses innovative equipment, a micro-laboratory and an analytical laboratory. Additionally, this facility is cGMP certified, and meets all FDA requirements for nutritional supplement manufacturing. For more information or to request a quote, go to

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Blue Door Pharma and Global Energy Markets Strike Global Export Agreement for Meningitis Vaccine and Pharmaceuticals
2. Devalued and distrusted: Can the pharmaceutical industry restore its broken image?
3. UBC professor wins Canadas top pharmaceutical research award
4. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
5. Environmentally friendly chemistry important for manufacturing pharmaceuticals
6. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
7. Medical care presents update on pharmaceutical health services research
8. Scientists use sound waves to levitate liquids, improve pharmaceuticals
9. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
10. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
11. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
Post Your Comments:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... 25, 2015 , ... Many people know of the common symptoms of low ... dry skin. But many people who find their cholesterol levels and weight are creeping ... thyroid, especially if they don’t have any of the other symptoms. , Thyroid hormone ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or ... today that the first patient has been enrolled in ... treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... 1/2 clinical trial, ESSA intends to demonstrate the safety, ...
(Date:11/24/2015)... 2015 --> --> ... Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet ... Posterior Lumbar Interbody Fusion), End User, and Geography - Global ... valued at $1.90 Billion in 2014 and is expected to ... during the forecast period of 2015 to 2020. ...
(Date:11/24/2015)... 24, 2015 . ... adds Latest Guidebook for Chinese Medical Device ... published in November 2015 to the medical devices ... library at . ... growing global economies with a fifth population in ...
Breaking Medicine Technology: